Sharon Aviram

609 total citations
14 papers, 441 citations indexed

About

Sharon Aviram is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Sharon Aviram has authored 14 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Cell Biology and 3 papers in Physiology. Recurrent topics in Sharon Aviram's work include Adipose Tissue and Metabolism (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Sharon Aviram is often cited by papers focused on Adipose Tissue and Metabolism (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Sharon Aviram collaborates with scholars based in Israel, United States and United Kingdom. Sharon Aviram's co-authors include Karl Skorecki, Daniel Kornitzer, Eyal Bengal, Tony Hayek, Walter G. Wasser, Ami Aronheim, Etty Kruzel-Davila, Joanna Mikulak, Aakash Jhaveri and Pravin C. Singhal and has published in prestigious journals such as Molecular and Cellular Biology, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Sharon Aviram

13 papers receiving 434 citations

Peers

Sharon Aviram
Alexander Artishevsky United States
Hongxiu Wen United States
Kelly M. England United States
Sharon Aviram
Citations per year, relative to Sharon Aviram Sharon Aviram (= 1×) peers Yasuyuki Shinozaki

Countries citing papers authored by Sharon Aviram

Since Specialization
Citations

This map shows the geographic impact of Sharon Aviram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Aviram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Aviram more than expected).

Fields of papers citing papers by Sharon Aviram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Aviram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Aviram. The network helps show where Sharon Aviram may publish in the future.

Co-authorship network of co-authors of Sharon Aviram

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Aviram. A scholar is included among the top collaborators of Sharon Aviram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Aviram. Sharon Aviram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bengal, Eyal & Sharon Aviram. (2025). p38α MAPK Regulation of Energy Metabolism in Skeletal Muscle Offers a Therapeutic Path for Type 2 Diabetes. Cells. 14(16). 1277–1277. 1 indexed citations
2.
Aviram, Sharon, et al.. (2025). Bidirectional Interaction in Cardio-Oncology Toward Novel Therapeutic Strategies for Cardiovascular Diseases. JACC CardioOncology. 7(5). 554–558.
3.
Aviram, Sharon, et al.. (2024). P38α MAPK Coordinates Mitochondrial Adaptation to Caloric Surplus in Skeletal Muscle. International Journal of Molecular Sciences. 25(14). 7789–7789. 1 indexed citations
4.
Aviram, Sharon, et al.. (2023). Heart Failure Promotes Cancer Progression in an Integrin β1-Dependent Manner. International Journal of Molecular Sciences. 24(24). 17367–17367. 4 indexed citations
5.
Singh, Preeti, Sharon Aviram, Neta Ilan, et al.. (2021). Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3. Matrix Biology. 105. 17–30. 14 indexed citations
6.
Bengal, Eyal, Sharon Aviram, & Tony Hayek. (2020). p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?. International Journal of Molecular Sciences. 21(18). 6480–6480. 63 indexed citations
7.
Korin, Ben, et al.. (2019). ATF3 and JDP2 deficiency in cancer associated fibroblasts promotes tumor growth via SDF-1 transcription. Oncogene. 38(20). 3812–3823. 21 indexed citations
8.
Aviram, Sharon, et al.. (2018). WDR62 mediates TNFα-dependent JNK activation via TRAF2-MLK3 axis. Molecular Biology of the Cell. 29(20). 2470–2480. 14 indexed citations
9.
Kalfon, Roy, et al.. (2016). ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance. Cardiovascular Research. 113(2). 134–146. 40 indexed citations
10.
Kruzel-Davila, Etty, Walter G. Wasser, Sharon Aviram, & Karl Skorecki. (2015). APOL1nephropathy: from gene to mechanisms of kidney injury. Nephrology Dialysis Transplantation. 31(3). 349–358. 72 indexed citations
11.
Aviram, Sharon, et al.. (2015). The association of the JNK scaffold protein, WDR62, with the mixed lineage kinase 3, MLK3. Research Explorer (The University of Manchester). 4(1). 5 indexed citations
12.
Lan, Xiqian, Aakash Jhaveri, Kang Cheng, et al.. (2014). APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability. American Journal of Physiology-Renal Physiology. 307(3). F326–F336. 138 indexed citations
13.
Aviram, Sharon & Daniel Kornitzer. (2009). The Ubiquitin Ligase Hul5 Promotes Proteasomal Processivity. Molecular and Cellular Biology. 30(4). 985–994. 54 indexed citations
14.
Aviram, Sharon, Einav Simon, Tsvia Gildor, Fabian Glaser, & Daniel Kornitzer. (2008). Autophosphorylation-Induced Degradation of the Pho85 Cyclin Pcl5 Is Essential for Response to Amino Acid Limitation. Molecular and Cellular Biology. 28(22). 6858–6869. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026